跳至主要内容
临床试验/NCT05964244
NCT05964244尚未招募不适用

Evaluate the Impact of Noninvasive (NIV) With Expiratory Washout on Respiratory Rate of Patients With Acute Hypercapnic Respiratory Failure. A Prospective, Randomized Cross Over Pilot Investigation.

Fisher and Paykel Healthcare0 个研究点目标入组 20 人开始时间: 2023年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20
主要终点
Change in respiratory rate

研究概览

简要总结

This study will determine if NIV using the Vela investigational mask with expiratory washout of the upper airway more effectively reduces respiratory rate in acute patients with hypercapnic respiratory failure. Patients admitted to hospital with acute respiratory failure (ARF) will be assessed for hypercapnic ARF by normal hospital protocols. Patients requiring noninvasive ventilation (NIV) will be set up on NIV as prescribed per standard of care. Enrollment onto the investigation will occur after the patient has been allowed to stabilize on NIV . Patients that meet the inclusion/exclusion criteria will be approached for consent. Investigation participants will receive two masks in random order;

  1. NIV for one hour with the investigational mask (Vela)
  2. NIV for one hour with the standard mask (Nivairo).

Participants will have their physiological respiratory parameters recorded.

详细描述

This is a simple study. Patients who are already on noninvasive ventilation (NIV) for acute respiratory failure will be approached for the study within the first 24 hours on NIV therapy.

The study will be conducted as described above. After the study patients will be able to choose which mask they continue their NIV on. They will continue NIV as part of their normal hospital care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

NIV masks can not be masked during the treatments. Only the analysis will be masked.

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have type II acute respiratory failure (ARF) and have been prescribed NIV
  • Arterial blood gas (ABG) Partial pressure of arterial carbon dioxide greater or equal to 6.0 kilopascals (45 millimeters of mercury)
  • Arterial blood gas acidity greater or equal to 7.35 prior to bilevel commencement
  • On NIV for 24 hours or less
  • Negative Covid-19 test
  • Are 18 years or older

排除标准

  • Contraindicated for NIV
  • On NIV in Emergency Department/ ward for more than 24 hours, within the last 48 hours
  • NIV is likely to fail and/or intubation be required, at the doctor's discretion
  • CPAP or bilevel pressure of 25 centimeters of water or more is required
  • Unable to tolerate NIV for the duration of the investigation
  • Do not fit the investigational mask or the standard mask
  • Pregnancy (tested under standard care)
  • Unable to understand the consent process

结局指标

主要结局

Change in respiratory rate

时间窗: 1 hour

The change in patient's respiratory rate over the 1 hour of the study arm

次要结局

未报告次要终点

研究者

发起方
Fisher and Paykel Healthcare
申办方类型
Industry
责任方
Sponsor

相似试验

Impact of Noninvasive With Expiratory Washout on... | 临床试验